Evidence map›Paper›PMID 35073606›Full record

ReviewGenes to cells : devoted to molecular & cellular mechanisms2022

Roles of the second messenger c-di-GMP in bacteria: Focusing on the topics of flagellar regulation and Vibrio spp.

Michio Homma, Seiji Kojima

Abstract readReview
In one paragraph

Review in Genes to cells : devoted to molecular & cellular mechanisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. LtrB inhibitsCurrent research in food science · 2026
    Article
  4. AphA-dependent c-di-GMP production inJournal of bacteriology · 2025
    Article
  5. CalR is an activator of biofilm formation inApplied and environmental microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Journal of bacteriology · 2023
    Article
  12. UropathogenicMicroorganisms · 2023
    Review
  13. Article
  14. Article
  15. Visualization of c-di-GMP in multicellularFrontiers in cell and developmental biology · 2023
    Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michio HommaDivision of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.ORCID https://orcid.org/0000-0002-5371-001X
Seiji KojimaDivision of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan.ORCID https://orcid.org/0000-0002-5582-8935

Funding

Japan Society for the Promotion of Science 20H03220
6 · The paper itself

Abstract

Typical second messengers include cyclic AMP (cAMP), cyclic GMP (cGMP), and inositol phosphate. In bacteria, cyclic diguanylate (c-di-GMP), which is not used in animals, is widely used as a second messenger for environmental responses. Initially found as a regulator of cellulose synthesis, this small molecule is known to be widely present in bacteria. A wide variety of synthesis and degradation enzymes for c-di-GMP exist, and the activities of effector proteins are regulated by changing the cellular c-di-GMP concentration in response to the environment. It has been shown well that c-di-GMP plays an essential role in pathogenic cycle and is involved in flagellar motility in Vibrio cholerae. In this review, we aim to explain the direct or indirect regulatory mechanisms of c-di-GMP in bacteria, focusing on the study of c-di-GMP in Vibrio spp. and in flagella, which are our research subjects.

Indexed as

Escherichia coli ProteinsVibrio choleraeBacterial ProteinsBiofilmsCyclic GMPGene Expression Regulation, BacterialSecond Messenger SystemsBacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPEscherichia coli Proteinsbacterial flagellumenergy transductiongene regulationmolecular motormotilityrotary nano-machinesignal transduction

Identifiers

PMID35073606
PMCPMC9303241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.